Concepts (188)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Nasal Septal Perforation | 5 | 2019 | 8 | 3.80 | Why? |
| Surgical Flaps | 5 | 2018 | 188 | 2.60 | Why? |
| Nasal Septum | 4 | 2018 | 44 | 2.29 | Why? |
| Olfaction Disorders | 18 | 2021 | 3704 | 1.88 | Why? |
| Endoscopy | 8 | 2020 | 1564 | 1.62 | Why? |
| Nasal Surgical Procedures | 2 | 2019 | 102 | 1.37 | Why? |
| Skull Base | 2 | 2020 | 246 | 1.24 | Why? |
| Nasal Obstruction | 4 | 2018 | 131 | 1.13 | Why? |
| Nose Diseases | 2 | 2020 | 139 | 0.89 | Why? |
| Sinusitis | 6 | 2020 | 649 | 0.87 | Why? |
| Rhinitis | 5 | 2019 | 626 | 0.87 | Why? |
| Taste Disorders | 7 | 2021 | 1720 | 0.86 | Why? |
| Rhinoplasty | 2 | 2018 | 78 | 0.83 | Why? |
| Translations | 1 | 2020 | 153 | 0.81 | Why? |
| Rhinomanometry | 2 | 2018 | 18 | 0.77 | Why? |
| Skull | 1 | 2018 | 48 | 0.74 | Why? |
| Rhinitis, Allergic | 3 | 2021 | 704 | 0.72 | Why? |
| Nasal Polyps | 2 | 2019 | 221 | 0.72 | Why? |
| Reconstructive Surgical Procedures | 2 | 2018 | 860 | 0.70 | Why? |
| Natural Orifice Endoscopic Surgery | 1 | 2019 | 127 | 0.69 | Why? |
| Leukotriene Antagonists | 1 | 2017 | 37 | 0.68 | Why? |
| Acetates | 1 | 2017 | 123 | 0.62 | Why? |
| Craniotomy | 1 | 2017 | 123 | 0.61 | Why? |
| Language | 1 | 2020 | 655 | 0.58 | Why? |
| Food Hypersensitivity | 1 | 2021 | 397 | 0.57 | Why? |
| Quinolines | 1 | 2017 | 403 | 0.51 | Why? |
| Smell | 6 | 2020 | 1851 | 0.46 | Why? |
| Olfactory Bulb | 3 | 2020 | 333 | 0.45 | Why? |
| Cadaver | 3 | 2018 | 626 | 0.39 | Why? |
| Interneurons | 2 | 2019 | 13 | 0.38 | Why? |
| Neurogenesis | 2 | 2019 | 64 | 0.37 | Why? |
| Dopaminergic Neurons | 2 | 2019 | 59 | 0.36 | Why? |
| Brain Injuries, Traumatic | 2 | 2018 | 381 | 0.24 | Why? |
| N-Methylaspartate | 2 | 2019 | 13 | 0.23 | Why? |
| Asthma | 1 | 2021 | 4383 | 0.23 | Why? |
| Olfactory Pathways | 1 | 2020 | 16 | 0.22 | Why? |
| Models, Neurological | 1 | 2020 | 121 | 0.20 | Why? |
| Olfactory Receptor Neurons | 1 | 2020 | 110 | 0.20 | Why? |
| Respiratory Hypersensitivity | 1 | 2020 | 103 | 0.19 | Why? |
| Personal Protective Equipment | 2 | 2021 | 15978 | 0.18 | Why? |
| Lateral Ventricles | 1 | 2017 | 6 | 0.18 | Why? |
| Betacoronavirus | 8 | 2020 | 204454 | 0.17 | Why? |
| Neurotoxins | 1 | 2017 | 42 | 0.17 | Why? |
| Dermatitis, Allergic Contact | 1 | 2021 | 185 | 0.17 | Why? |
| Angiofibroma | 1 | 2017 | 7 | 0.17 | Why? |
| Rhinitis, Allergic, Perennial | 1 | 2017 | 36 | 0.17 | Why? |
| Patient Advocacy | 1 | 2019 | 173 | 0.17 | Why? |
| Quality of Life | 7 | 2020 | 9820 | 0.17 | Why? |
| Neurologic Examination | 1 | 2020 | 428 | 0.17 | Why? |
| Sulfides | 1 | 2017 | 113 | 0.16 | Why? |
| Nasopharyngeal Neoplasms | 1 | 2017 | 64 | 0.16 | Why? |
| Goals | 1 | 2019 | 335 | 0.15 | Why? |
| Monitoring, Intraoperative | 1 | 2017 | 140 | 0.15 | Why? |
| Medical Overuse | 1 | 2018 | 146 | 0.15 | Why? |
| North America | 1 | 2020 | 1400 | 0.15 | Why? |
| Desensitization, Immunologic | 1 | 2021 | 574 | 0.15 | Why? |
| Humans | 42 | 2021 | 930598 | 0.15 | Why? |
| Dermatitis, Atopic | 2 | 2021 | 714 | 0.15 | Why? |
| Postoperative Period | 1 | 2017 | 651 | 0.14 | Why? |
| Cyclopropanes | 1 | 2017 | 332 | 0.14 | Why? |
| Paranasal Sinuses | 1 | 2017 | 217 | 0.14 | Why? |
| Pituitary Neoplasms | 1 | 2017 | 130 | 0.14 | Why? |
| Disease Outbreaks | 2 | 2021 | 27595 | 0.14 | Why? |
| Male | 25 | 2021 | 367725 | 0.14 | Why? |
| Infection Control | 2 | 2021 | 23131 | 0.14 | Why? |
| Ethanol | 1 | 2020 | 533 | 0.14 | Why? |
| Reference Values | 1 | 2017 | 795 | 0.14 | Why? |
| Nasal Cavity | 2 | 2018 | 909 | 0.14 | Why? |
| Drug Hypersensitivity | 1 | 2021 | 401 | 0.14 | Why? |
| Pneumonia, Viral | 8 | 2020 | 243684 | 0.14 | Why? |
| Adenoma | 1 | 2017 | 215 | 0.13 | Why? |
| Coronavirus Infections | 8 | 2020 | 253789 | 0.13 | Why? |
| Neurosurgical Procedures | 2 | 2017 | 1738 | 0.13 | Why? |
| Tomography, X-Ray Computed | 2 | 2018 | 25144 | 0.13 | Why? |
| Integrin alpha2 | 1 | 2012 | 8 | 0.13 | Why? |
| Integrin beta3 | 1 | 2012 | 35 | 0.13 | Why? |
| Administration, Intranasal | 1 | 2017 | 1132 | 0.13 | Why? |
| Asia | 1 | 2020 | 2399 | 0.12 | Why? |
| Female | 22 | 2021 | 380317 | 0.12 | Why? |
| Radiography | 2 | 2018 | 1576 | 0.12 | Why? |
| L-Lactate Dehydrogenase | 1 | 2021 | 1995 | 0.12 | Why? |
| Adult | 16 | 2021 | 244371 | 0.11 | Why? |
| Chronic Disease | 4 | 2019 | 5139 | 0.11 | Why? |
| Neurodegenerative Diseases | 1 | 2017 | 469 | 0.11 | Why? |
| Spain | 5 | 2020 | 15545 | 0.11 | Why? |
| Cross-Sectional Studies | 5 | 2020 | 53120 | 0.11 | Why? |
| Hearing Loss, Sudden | 1 | 2012 | 103 | 0.10 | Why? |
| Middle Aged | 16 | 2021 | 270681 | 0.10 | Why? |
| Hearing Loss, Sensorineural | 1 | 2012 | 159 | 0.10 | Why? |
| Pandemics | 9 | 2021 | 389249 | 0.10 | Why? |
| Telemedicine | 1 | 2021 | 25032 | 0.10 | Why? |
| Intracranial Aneurysm | 1 | 2014 | 504 | 0.09 | Why? |
| Feasibility Studies | 1 | 2018 | 3467 | 0.09 | Why? |
| Aged, 80 and over | 7 | 2020 | 88759 | 0.09 | Why? |
| Aged | 11 | 2021 | 215776 | 0.09 | Why? |
| Respiratory System | 1 | 2020 | 3213 | 0.08 | Why? |
| Outpatients | 1 | 2020 | 3417 | 0.08 | Why? |
| Polymerase Chain Reaction | 2 | 2020 | 6740 | 0.08 | Why? |
| Public Health Surveillance | 1 | 2020 | 3129 | 0.08 | Why? |
| Magnetic Resonance Imaging | 3 | 2018 | 6551 | 0.08 | Why? |
| Symptom Assessment | 1 | 2020 | 4967 | 0.08 | Why? |
| Case-Control Studies | 3 | 2020 | 17671 | 0.08 | Why? |
| Biological Products | 1 | 2021 | 2331 | 0.08 | Why? |
| Prospective Studies | 7 | 2021 | 43301 | 0.08 | Why? |
| Rats, Sprague-Dawley | 2 | 2019 | 987 | 0.07 | Why? |
| Patient Safety | 1 | 2020 | 4885 | 0.07 | Why? |
| Occupational Health | 1 | 2020 | 3965 | 0.07 | Why? |
| Otolaryngology | 1 | 2018 | 1917 | 0.07 | Why? |
| Reproducibility of Results | 1 | 2020 | 11304 | 0.07 | Why? |
| Drug Therapy, Combination | 1 | 2017 | 7268 | 0.06 | Why? |
| Adrenal Cortex Hormones | 2 | 2018 | 6537 | 0.06 | Why? |
| Europe | 1 | 2020 | 12702 | 0.06 | Why? |
| Interleukin-6 | 1 | 2021 | 7522 | 0.06 | Why? |
| Disease Management | 1 | 2021 | 6841 | 0.06 | Why? |
| Young Adult | 4 | 2020 | 93724 | 0.06 | Why? |
| Follow-Up Studies | 2 | 2017 | 17020 | 0.06 | Why? |
| Severity of Illness Index | 5 | 2021 | 48226 | 0.06 | Why? |
| Jugular Veins | 1 | 2001 | 52 | 0.05 | Why? |
| Rats | 2 | 2019 | 2764 | 0.05 | Why? |
| Discrimination Learning | 1 | 2019 | 3 | 0.05 | Why? |
| Excitatory Amino Acid Agonists | 1 | 2019 | 8 | 0.05 | Why? |
| Virus Diseases | 1 | 2018 | 3779 | 0.05 | Why? |
| Algorithms | 1 | 2017 | 7346 | 0.05 | Why? |
| Peptidyl-Dipeptidase A | 1 | 2021 | 9659 | 0.05 | Why? |
| Primary Health Care | 1 | 2018 | 4839 | 0.05 | Why? |
| Rhinometry, Acoustic | 1 | 2018 | 8 | 0.05 | Why? |
| Age Factors | 1 | 2020 | 21039 | 0.05 | Why? |
| Self Report | 2 | 2021 | 3802 | 0.05 | Why? |
| Olfactory Mucosa | 1 | 2021 | 372 | 0.04 | Why? |
| Prevalence | 4 | 2020 | 25773 | 0.04 | Why? |
| Pituitary Hormones | 1 | 2017 | 6 | 0.04 | Why? |
| Visual Analog Scale | 1 | 2017 | 151 | 0.04 | Why? |
| Expectorants | 1 | 2018 | 95 | 0.04 | Why? |
| Odorants | 1 | 2019 | 219 | 0.04 | Why? |
| Sensory Thresholds | 1 | 2018 | 115 | 0.04 | Why? |
| Sensation Disorders | 1 | 2017 | 103 | 0.04 | Why? |
| Histamine Antagonists | 1 | 2018 | 203 | 0.04 | Why? |
| China | 2 | 2021 | 50654 | 0.04 | Why? |
| Health Personnel | 3 | 2021 | 29646 | 0.04 | Why? |
| Surveys and Questionnaires | 2 | 2021 | 43792 | 0.04 | Why? |
| Acute Disease | 2 | 2020 | 6029 | 0.04 | Why? |
| Visual Fields | 1 | 2017 | 123 | 0.04 | Why? |
| Costs and Cost Analysis | 1 | 2020 | 694 | 0.04 | Why? |
| Sphenoid Bone | 1 | 2014 | 13 | 0.04 | Why? |
| Protective Factors | 1 | 2021 | 1720 | 0.04 | Why? |
| Down-Regulation | 1 | 2021 | 1416 | 0.04 | Why? |
| Bias | 1 | 2020 | 1109 | 0.03 | Why? |
| Physicians, Primary Care | 1 | 2018 | 298 | 0.03 | Why? |
| Endoscopes | 1 | 2014 | 72 | 0.03 | Why? |
| Treatment Outcome | 2 | 2017 | 51732 | 0.03 | Why? |
| Analysis of Variance | 1 | 2017 | 950 | 0.03 | Why? |
| Logistic Models | 2 | 2020 | 9089 | 0.03 | Why? |
| Chi-Square Distribution | 1 | 2017 | 961 | 0.03 | Why? |
| Health Status Indicators | 1 | 2017 | 341 | 0.03 | Why? |
| Conjunctivitis | 1 | 2017 | 318 | 0.03 | Why? |
| Respiratory Function Tests | 1 | 2020 | 1755 | 0.03 | Why? |
| Ventilation | 1 | 2020 | 1145 | 0.03 | Why? |
| Polymorphism, Restriction Fragment Length | 1 | 2012 | 116 | 0.03 | Why? |
| Hospitalization | 2 | 2021 | 54280 | 0.03 | Why? |
| Mexico | 1 | 2020 | 2787 | 0.03 | Why? |
| Patient Participation | 1 | 2019 | 829 | 0.03 | Why? |
| Homozygote | 1 | 2012 | 230 | 0.03 | Why? |
| Hypersensitivity | 1 | 2021 | 1137 | 0.03 | Why? |
| Recovery of Function | 1 | 2021 | 2461 | 0.03 | Why? |
| Image Processing, Computer-Assisted | 1 | 2017 | 1383 | 0.02 | Why? |
| History, 20th Century | 1 | 2014 | 1282 | 0.02 | Why? |
| Child | 4 | 2018 | 70012 | 0.02 | Why? |
| Gene Frequency | 1 | 2012 | 1210 | 0.02 | Why? |
| Adolescent | 4 | 2020 | 86841 | 0.02 | Why? |
| Evidence-Based Medicine | 1 | 2019 | 3228 | 0.02 | Why? |
| Venous Thrombosis | 1 | 2001 | 2739 | 0.02 | Why? |
| ROC Curve | 1 | 2018 | 6024 | 0.02 | Why? |
| Retrospective Studies | 4 | 2021 | 105322 | 0.02 | Why? |
| Polymorphism, Genetic | 1 | 2012 | 1074 | 0.02 | Why? |
| Animals | 3 | 2019 | 78931 | 0.02 | Why? |
| Referral and Consultation | 1 | 2017 | 4816 | 0.01 | Why? |
| Genotype | 1 | 2012 | 4697 | 0.01 | Why? |
| Mass Screening | 1 | 2020 | 8005 | 0.01 | Why? |
| Disease Models, Animal | 1 | 2017 | 10998 | 0.01 | Why? |
| Disease Progression | 1 | 2018 | 13580 | 0.01 | Why? |
| Anti-Inflammatory Agents | 1 | 2017 | 6153 | 0.01 | Why? |
| Genetic Predisposition to Disease | 1 | 2012 | 4027 | 0.01 | Why? |
| Biomarkers | 1 | 2020 | 23361 | 0.01 | Why? |
| Syndrome | 1 | 2001 | 1310 | 0.01 | Why? |
| Anti-Bacterial Agents | 1 | 2018 | 10083 | 0.01 | Why? |
| Comorbidity | 1 | 2017 | 34796 | 0.01 | Why? |
| Cardiovascular Diseases | 1 | 2012 | 11497 | 0.01 | Why? |
| Risk Factors | 1 | 2012 | 71621 | 0.00 | Why? |
Alobid's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(188)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(185)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_